Inicio>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>N-Acetylneuraminic acid

N-Acetylneuraminic acid (Synonyms: NANA, Neu5Ac)

Catalog No.GC15129

El Ácido N-acetilneuramÍnico es un monosacÁrido de Ácido siÁlico de nueve carbonos que se encuentra comÚnmente en las glicoproteÍnas de las membranas celulares y en los glicolÍpidos, como los gangliÓsidos en las células de los mamÍferos.

Products are for research use only. Not for human use. We do not sell to patients.

N-Acetylneuraminic acid Chemical Structure

Cas No.: 131-48-6

Tamaño Precio Disponibilidad Cantidad
100mg
38,00 $
Disponible
500mg
75,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

N-Acetylneuraminic acid is a nine-carbon, sialic acid monosaccharide commonly found in glycoproteins on cell membranes and in glycolipids such as gangliosides in mammalian cells. Studies suggest that N-Acetylneuraminic acid is useful biologically in neurotransmission, leukocyte extravasation, viral or bacterial infections and carbohydrate-protein recognition.

References:
[1]. Bondioli L et al. PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid. Biomaterials. 2010 Apr;31(12):3395-403.
[2]. Bondioli L et al. PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid. Biomaterials. 2010 Apr;31(12):3395-403.

Reseñas

Review for N-Acetylneuraminic acid

Average Rating: 5 ★★★★★ (Based on Reviews and 38 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for N-Acetylneuraminic acid

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.